InflaRx (IFRX) Inventory (2023 - 2024)
InflaRx's (IFRX) quarterly Inventory came in at $7.4 million in Q4 2024, down 39.74% year-on-year from $12.2 million in Q1 2024, and down 39.74% quarter-over-quarter from $12.2 million in Q4 2023.
InflaRx (IFRX) Inventory (2023 - 2024) Analysis & Trends
InflaRx has disclosed Inventory across 2 years of filings, most recently posting $7.4 million for Q4 2024.
- Inventory for Q4 2024 came in at $7.4 million, down 39.74% year-over-year; the trailing twelve-month figure through Dec 2024 was $7.4 million (down 39.74% YoY), and the FY2024 annual result was $7.4 million, down 39.74% from the prior year.
- Inventory came in at $7.4 million for Q4 2024 at InflaRx, down from $12.2 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $12.2 million in Q4 2023 to a low of $7.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 12.23 Mn |